An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Karuna Therapeutics to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Karuna Therapeutics (NASDAQ: KRTX), a biopharmaceutical company focused on treatments for psychiatric and neurological conditions, announced participation in virtual investor conferences. Management will present at the Guggenheim 3rd Annual Neuro/Immunology Conference on November 15, 2021 at 11:00 a.m. ET, and at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021 at 10:40 a.m. ET. Webcasts for both events will be available on their Investor Relations page.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will participate in fireside chats at the following upcoming virtual investor conferences:
Guggenheim 3rd Annual Neuro/Immunology Conference Date: November 15, 2021 Time: 11:00 a.m. ET
Stifel 2021 Virtual Healthcare Conference Date: November 16, 2021 Time: 10:40 a.m. ET
A live webcast of the fireside chats will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcasts will also be archived for up to 30 days on Karuna’s website following the conference.
About Karuna Therapeutics
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in people's lives. For more information, please visit www.karunatx.com.
What are the upcoming investor conferences for Karuna Therapeutics (KRTX)?
Karuna Therapeutics (KRTX) will participate in the Guggenheim 3rd Annual Neuro/Immunology Conference on November 15, 2021, at 11:00 a.m. ET and the Stifel 2021 Virtual Healthcare Conference on November 16, 2021, at 10:40 a.m. ET.
Where can I watch the Karuna Therapeutics (KRTX) conference presentations?
You can watch the live webcasts of the presentations on Karuna Therapeutics' Investor Relations page at investors.karunatx.com.
How long will the Karuna Therapeutics (KRTX) webcasts be available after the conferences?
The webcasts will be archived on Karuna's website for up to 30 days following the conferences.
